Ultimo aggiornamento: agosto 17, 2026

  • Stem Cell Therapy for Portal Hypertension in Liver Cirrhosis: New Regenerative Approaches (2026)

Meta descrizione:
Can stem cell therapy reduce portal hypertension in cirrhosis? Discover how regenerative medicine improves liver circulation and lowers portal pressure.


Introduzione

Portal hypertension is one of the most serious complications of liver cirrhosis and a major cause of:

  • Ascite
  • Sanguinamento da varici
  • Liver decompensation

Tradizionalmente, treatment focuses on symptom control, not the underlying cause.

Tuttavia, modern advances in Terapia con cellule staminali per la cirrosi are changing this approach by targeting:
✔ liver fibrosis
✔ vascular resistance
✔ hepatic microcirculation


What Is Portal Hypertension?

Domanda: What causes portal hypertension?
Risposta:
Portal hypertension occurs when blood flow through the liver is obstructed due to:

  • Fibrosis and scar tissue
  • Distorted liver architecture
  • Increased intrahepatic resistance

This leads to increased pressure in the portal vein and complications throughout the body.


Why Portal Hypertension Is Dangerous

Domanda: What complications does it cause?
Risposta:

  • Esophageal varices (risk of bleeding)
  • Ascite (fluid accumulation)
  • Splenomegaly
  • Encefalopatia epatica

It is one of the main reasons cirrhosis becomes life-threatening.


How Stem Cell Therapy Helps Reduce Portal Hypertension

1. Reduction of Intrahepatic Resistance

Stem cells reduce fibrosis and improve liver elasticity, allowing blood to flow more freely through the liver.

➡️ This directly lowers portal pressure.


2. Improvement of Liver Microcirculation

Domanda: Can stem cells improve liver blood flow?
Risposta:
SÌ. Stem cells enhance microvascular function by:

  • Promoting angiogenesis
  • Repairing endothelial cells
  • Improving oxygen delivery

3. Effetti antifibrotici

Riducendo il tessuto cicatriziale, stem cells help restore normal vascular pathways in the liver.

This leads to improved circulation and reduced pressure in the portal system.


4. Anti-inflammatory Action

Chronic inflammation worsens vascular resistance. Stem cells suppress inflammatory signals, improving overall liver function and blood flow.


Stem Cell Types Used in Portal Hypertension

Cellule staminali mesenchimali (MSC)

MSCs are most commonly used because they:

  • Reduce fibrosis
  • Migliora la funzione vascolare
  • Are safe in clinical applications

Terapia degli esosomi

Exosomes derived from stem cells deliver regenerative signals that improve vascular health without direct cell transplantation.


Cellule progenitrici endoteliali (EPC)

These cells specifically target blood vessels and may play a role in restoring hepatic circulation.


Recent Clinical Findings (2025–2026)

Recent studies suggest:

  • Reduction in portal pressure after stem cell therapy
  • Improved liver perfusion
  • Decrease in ascites formation
  • Better overall liver function

These findings indicate that regenerative therapy can target the root cause of portal hypertension, not just symptoms.


Can Stem Cell Therapy Prevent Variceal Bleeding?

Domanda: Can reducing portal pressure prevent complications?
Risposta:
SÌ. By lowering portal pressure, stem cell therapy may reduce the risk of:

  • Esophageal varices rupture
  • Internal bleeding
  • Hospitalization

This makes it a promising preventive strategy.


Metodi di consegna

Stem cells can be administered through:

  • Infusione endovenosa
  • Hepatic artery injection
  • Portal vein delivery

Targeted delivery methods may improve outcomes in vascular complications.


Considerazioni sulla sicurezza

Domanda: Is it safe to use stem cells in patients with portal hypertension?
Risposta:
SÌ, current studies show:

  • Good safety profile
  • Minimal adverse effects
  • No increase in complications

Direzioni future

Emerging approaches include:

  • Gene-enhanced stem cells targeting vascular resistance
  • Combination therapy with beta-blockers
  • AI-based monitoring of portal pressure
  • Bioengineered vascular repair systems

Conclusione

Portal hypertension is one of the most dangerous complications of cirrhosis, but stem cell therapy offers a new approach by addressing its root causes.

By improving liver structure and circulation, la medicina rigenerativa può:

  • Reduce portal pressure
  • Migliora la funzionalità epatica
  • Prevent complications

This represents a major step forward in treating advanced liver disease.

Revisione scientifica di casi

Revisione scientifica del caso

Ti piacerebbe capire se i programmi clinici sono attuali, recenti sviluppi della ricerca, o potrebbero esserlo gli approcci emergenti rilevante per la tua situazione individuale?

Invia la tua domanda al nostro team scientifico. La sede centrale di NBScience nel Regno Unito coordina le richieste attraverso la rete internazionale di centri medici, scienziati, e consulenti specializzati.

  • Revisione delle informazioni fornite
  • Informazioni rilevanti sulla ricerca e sul programma clinico
  • Una risposta chiara focalizzata sulla tua situazione
Cosa succede dopo? Invia la tua domanda, ricevere una revisione scientifica mirata, e ottieni una risposta chiara sulla ricerca e sui programmi clinici rilevanti per la tua situazione.
La tua revisione scientifica sarà preparata da Dott. Helen Melnik,Dottorato di ricerca , chi ha più di 25 anni di esperienza nella ricerca sulle cellule staminali e nei programmi clinici internazionali.

Nessun obbligo. La tua domanda verrà esaminata in modo confidenziale.

Solo informazioni didattiche e di ricerca. Questo servizio no costituiscono un parere medico, diagnosi, prescrizione, o uno personalizzato raccomandazione terapeutica.


NBScienza

organizzazione di ricerca a contratto

Whatsapp